文献速递消化道肿瘤与早癌

结直肠癌患者粪便样本灌胃促进无菌小鼠和常规小鼠肠道癌变

Gavage of Fecal Samples From Patients With Colorectal Cancer Promotes Intestinal Carcinogenesis in Germ-Free and Conventional Mice.
PubMed 文献 · Gastroenterology · 2017-08-18

该研究将结直肠癌患者与健康对照者的粪便灌胃给无菌小鼠和经氧化偶氮甲烷处理的常规小鼠,发现结直肠癌患者粪便可增加常规小鼠高级别异型增生和肉眼可见息肉的比例,提高无菌小鼠结肠增殖细胞比例,并改变肠道微生物组成及炎症相关细胞因子和Th1、Th17细胞比例。

要点

  • 结直肠癌患者粪便灌胃的常规小鼠高级别异型增生和肉眼可见息肉比例显著高于对照粪便灌胃组。
  • 结直肠癌患者粪便灌胃的无菌小鼠结肠Ki-67阳性增殖细胞比例高于对照粪便灌胃组。
  • 结直肠癌患者粪便灌胃的小鼠肠道微生物组成不同且丰富度降低,炎症相关细胞因子表达增加。

核心结论

  • 结直肠癌患者粪便微生物群可在无菌小鼠和给予致癌剂的常规小鼠中促进肿瘤发生。

研究设计与样本

  • 研究获取香港一项宏基因组研究中储存的粪便样本,将来自5例结直肠癌患者或5名健康对照者的粪便灌胃给常规雄性C57BL/6小鼠(饮水中给予抗生素后以氧化偶氮甲烷诱导结肠肿瘤)和无菌C57BL/6小鼠。
  • 常规小鼠每周灌胃两次、持续5周;无菌小鼠灌胃一次。
  • 对小鼠肠道组织进行组织学、免疫组化、表达微阵列、定量聚合酶链反应、免疫印迹和流式细胞术分析,并对小鼠粪便进行16S核糖体RNA基因测序分析。

主要发现

  • 常规小鼠中,接受结直肠癌患者粪便灌胃的组别发生高级别异型增生的比例显著高于对照粪便灌胃组(P < .05),发生肉眼可见息肉的比例也显著高于对照粪便灌胃组(P < .01)。
  • 无菌小鼠中,接受结直肠癌患者粪便灌胃的组别结肠Ki-67阳性增殖细胞比例高于对照粪便灌胃组(P < .05)。
  • 接受结直肠癌患者粪便灌胃的无菌小鼠和常规小鼠粪便微生物组成与对照粪便灌胃组不同,且接受结直肠癌患者粪便灌胃的小鼠微生物丰富度较低。
  • 接受结直肠癌患者粪便灌胃的常规小鼠和无菌小鼠肠道中调节炎症的细胞因子表达增加,包括C-X-C趋化因子受体1、C-X-C趋化因子受体2、白细胞介素17A(IL17A)、IL22和IL23A。
  • 接受结直肠癌患者粪便灌胃的常规小鼠和无菌小鼠肠道中Th1细胞比例(2.25% vs 0.44%)和Th17细胞比例(2.08% vs 0.31%)高于对照粪便灌胃组(P < .05)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Altered gut microbiota is implicated in development of colorectal cancer (CRC). Some intestinal bacteria have been reported to potentiate intestinal carcinogenesis by producing genotoxins, altering the immune response and intestinal microenvironment, and activating oncogenic signaling pathways. We investigated whether stool from patients with CRC could directly induce colorectal carcinogenesis in mice. METHODS: We obtained stored stool samples from participants in a metagenome study performed in Hong Kong. Conventional (male C57BL/6) mice were given azoxymethane to induce colon neoplasia after receiving a course of antibiotics in drinking water. Mice were gavaged twice weekly with stool from 5 patients with CRC or 5 healthy individuals (controls) for 5 weeks. Germ-free C57BL/6 mice were gavaged once with stool from 5 patients with CRC or 5 controls. We collected intestinal tissues from mice and performed histology, immunohistochemistry, expression microarray, quantitative polymerase chain reaction, immunoblot, and flow cytometry analyses. We performed 16S ribosomal RNA gene sequencing analysis of feces from mice. RESULTS: Significantly higher proportions of conventional mice fed with stool from individuals with CRC than control stool developed high-grade dysplasia (P < .05) and macroscopic polyps (P < .01). We observed a higher proportion of proliferating (Ki-67-positive) cells in colons of germ-free mice fed with stool from patients with CRC vs those fed with stool from controls (P < .05). Feces from germ-free and conventional mice fed with stool from patients with CRC vs controls contained different microbial compositions, with lower richness in mice fed with stool from patients with CRC. Intestines collected from conventional and germ-free mice fed with stool from patients with CRC had increased expression of cytokines that modulate inflammation, including C-X-C motif chemokine receptor 1, C-X-C motif chemokine receptor 2, interleukin 17A (IL17A), IL22, and IL23A. Intestines from conventional and germ-free mice fed with stool from patients with CRC contained higher proportions of T-helper 1 (Th1) cells (2.25% vs 0.44%) and Th17 cells (2.08% vs 0.31%) (P < .05 for each) than mice fed with stool from controls. Real-time polymerase chain reaction arrays revealed up-regulation of genes involved in cell proliferation, stemness, apoptosis, angiogenesis, invasiveness, and metastasis in mice fed with stool from patients with CRC. CONCLUSIONS: We fed stool samples from patients with CRC and heathy individuals to germ-free mice and conventional mice with azoxymethane. We found stool from patients with CRC to increase the numbers of polyps, levels of intestinal dysplasia and proliferation, markers of inflammation, and proportions of Th1 and Th17 cells in colon, compared with stool from individuals without CRC. This study provides evidence that the fecal microbiota from patients with CRC can promote tumorigenesis in germ-free mice and mice given a carcinogen.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Wong SH, Zhao L, Zhang X, et al. Gavage of Fecal Samples From Patients With Colorectal Cancer Promotes Intestinal Carcinogenesis in Germ-Free and Conventional Mice. Gastroenterology. 2017. PMID: 28823860. doi:10.1053/j.gastro.2017.08.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。